Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2009
12/17/2009CA2726512A1 Antibodies against neisserial factor h binding protein
12/17/2009CA2724660A1 Detection of cannabis use
12/17/2009CA2723995A1 Compounds for treating symptoms associated with parkinson's disease
12/17/2009CA2723991A1 Compounds for treating diseases
12/17/2009CA2723967A1 Compounds for treating amyloidoses
12/17/2009CA2720365A1 Bcr-complex-specific antibodies and methods of using same
12/17/2009CA2691055A1 Methods of converting fab sequences into single chain antibody sequences
12/16/2009WO2009154651A1 Treatment of metastic breast cancer by a combination of two anti-her2 antibodies and a taxene
12/16/2009EP2133423A1 Germ cell marker using fish vasa gene
12/16/2009EP2133365A2 Compositions and methods for the treatment of infections and tumors
12/16/2009EP2133362A1 Antagonists and agonists of LDCAM and methods of use
12/16/2009EP2132984A2 Interferon-like protein ZCYTO21
12/16/2009EP2132312A2 Constructs and libraries comprising antibody surrogate light chain sequences
12/16/2009EP2132230A2 Apoptotic anti-ige antibodies binding the membrane-bound ige
12/16/2009EP2132228A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
12/16/2009EP2132227A1 Composition of labeled and non-labeled monoclonal antibodies
12/16/2009EP2132226A2 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized ldl receptor-1 (lox-1)
12/16/2009EP2132223A1 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
12/16/2009EP2131863A1 A method of treating malignant mesothelioma
12/16/2009EP1751190B1 Spore specific antibodies
12/16/2009EP1716181B1 Cdr-repaired antibodies
12/16/2009EP1521832B1 Anti-fragilis antibody and uses thereof
12/16/2009EP1425028B1 Use of il-18 inhibitors for the treatement or prevention of sepsis
12/16/2009EP1384075B1 Methods of detecting early renal disease in animals
12/16/2009EP1287147B1 Immunotoxin fusion proteins and means for expression thereof
12/16/2009EP1012299B1 Lipid kinase
12/16/2009CN101606066A Method for analysis of hepatitis b virus s antigen
12/16/2009CN101606062A Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy
12/16/2009CN101605815A Method and arrangement for allowing enterprise and personal domains in the ims
12/16/2009CN101605814A Engineered anti-TSLP antibody
12/16/2009CN101605813A Method for increasing protein yields
12/16/2009CN101605812A CD44 antibodies
12/16/2009CN101605811A Treatment of cachexia
12/16/2009CN101605561A Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof
12/16/2009CN101605556A TRKB agonists for treating autoimmune disorders
12/16/2009CN101603047A Establishment of prokaryotic expression and purification as well as test method of reconstruction human kidney injury molecule 1 (KIM-1)
12/16/2009CN101603046A Establishment of prokaryotic expression and purification as well as test method of reconstruction influenza A H1N1 virus nonstructural protein NS1
12/16/2009CN101602808A Specific binding protein and application thereof
12/16/2009CN101602807A Mammalian cytokines, reagent and method thereof
12/16/2009CN101602806A Humanized antibodies against vascular endothelial growth factor
12/16/2009CN101602805A Agarose compatible medium for purifying immune globulin of hand-foot-and-mouth disease and preparation method thereof
12/16/2009CN101602794A Method for preparing human MGF polypeptide and antibody thereof
12/16/2009CN101602793A Immunoregulatory polypeptide for preventing and/or treating rheumatoid arthritis and application thereof
12/16/2009CN101601861A Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component
12/16/2009CN100569939C Product of transegenic plant for expressing coat protein of human rotavirus and use thereof for preventing infant diarrhea
12/16/2009CN100569800C Monoclonal antibody for resisting human myeloblast differentiation marker gene and its uses
12/15/2009US7632983 Expression of monoclonal antibodies in duckweed
12/15/2009US7632933 Corticotropin releasing factor 2 receptor agonists
12/15/2009US7632929 hapten compounds comprising either methamphetamine or amphetamine conjugated to a linker; therapy for drug overdose, decreases the concentration of methamphetamine, amphetamine, or MDMA in the brain of the subject
12/15/2009US7632926 Humanized monoclonal antibodies to hepatocyte growth factor
12/15/2009US7632925 Antibodies that bind human 17-A1/EpCAM tumor antigen
12/15/2009US7632923 Lymphotropic retrovirus disease treatment and diagnosis such as acquired immunodeficiency syndrome (AIDS); Specifically binds with high specificity and affinity a particular human APM:pathogen-derived antigen complex
12/15/2009US7632922 Osteoprotegerin
12/15/2009US7632816 Treatment of Alzheimer amyloid deposition
12/15/2009US7632650 Diagnostics and therapeutic uses of topors
12/15/2009US7632648 Screening a library of potential specific binders with at least one cyclic peptide for identifying specific binding partners for holoTC, having specificity for holoTC over apoTC of at least 40-fold
12/15/2009US7632646 Tuberculosis diagnostic test
12/15/2009US7632645 High throughput screening; signal transduction
12/15/2009US7632643 PCA3, PCA3 genes, and methods of use
12/15/2009US7632516 Moraxella catarrhalis BASB115 polypeptides
12/15/2009US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc
12/15/2009US7632510 Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence
12/15/2009US7632509 Methods to express recombinant proteins from lentiviral vectors
12/15/2009US7632504 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/15/2009US7632503 Using human insulin-like growth factor-1 (IGF-1) fusion protein as therapeutic in treatment and prevention of muscular disorders
12/15/2009US7632502 Immunoglobulin for diagnosis and prevention of yeast infections
12/15/2009US7632501 Antibodies against monocyte chemotactic proteins
12/15/2009US7632500 Immunoglobulin for use in prevention and treatment inflammatory disease
12/15/2009US7632497 Molecules having a variant Fc region, wherein region comprises at least one amino acid modification relative to a wild-type Fc region; modified molecules confer an effector function to a molecule, where the parent molecule does not detectably exhibit this effector function; utility in cancer treatment
12/15/2009US7632496 Administering to patient therapeutic dose of cytokine in combination with antibodies directed against tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN); method characterized in significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone
12/15/2009US7632495 Administering fibrinogen like protein 2 (fgl2) or a nucleic acid encoding it; preventing graft versus host rejection, autoimmune disease, and allergies; T-cell proliferation inhibitors
12/15/2009CA2456037C Paget disease of bone
12/15/2009CA2345138C Polymer conjugates of interferon beta-1a and their uses
12/15/2009CA2344049C Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway
12/15/2009CA2338000C Water-soluble 4-thio-maleimido derivatives and methods for their production
12/15/2009CA2308604C Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
12/10/2009WO2009149382A2 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
12/10/2009WO2009149370A1 Methods for the treatment of rheumatoid arthritis
12/10/2009WO2009149281A1 Immunotoxins and uses thereof
12/10/2009WO2009149189A2 Dual variable domain immunoglobulins and uses thereof
12/10/2009WO2009149185A2 Dual variable domain immunoglobulins and uses thereof
12/10/2009WO2009148928A1 Monoclonal antibodies to basic fibroblast growth factor
12/10/2009WO2009148628A2 Tyrosine phosphorylation sites in tnk1 kinase
12/10/2009WO2009148575A1 Interleukin-1 alpha abs and methods of use
12/10/2009WO2009148150A1 Device for detection of influenza virus
12/10/2009WO2009147530A2 Conformation specific antibodies that bind trefoil factors
12/10/2009WO2009147362A1 Method of rheumatoid arthritis treatment
12/10/2009WO2009147248A2 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
12/10/2009WO2009147201A2 Anti-inflammatory agents
12/10/2009WO2009147196A1 Hiv-rev-multimerization inhibiting nanobodies
12/10/2009WO2009146957A1 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof.
12/10/2009WO2009146956A1 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
12/10/2009WO2009126688A3 Novel compositions and methods for the treatment of immune related diseases
12/10/2009WO2009117640A3 Antibodies against interleukin-10 like cytokines and uses therefor
12/10/2009WO2009109860A3 Mutant forms of chlamydia htra
12/10/2009WO2009056634A3 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)
12/10/2009US20090307806 Genetic markers for high oleic acid content in plants
12/10/2009US20090307791 Calcium-activated chloride channel and methods of use thereof
12/10/2009US20090306578 Artificial receptors
12/10/2009US20090306349 Binding partners with immunoglobulin domains modified to have extended half-life